Familial Incidence of Cardiovascular Malformations in Hypoplastic Left Heart Syndrome

Angela M Kelle1, Muhammad Y Qureshi1, Timothy M Olson2

  • 1Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota.

Insights

Familial screening for cardiovascular malformations (CVMs) in relatives of hypoplastic left heart syndrome (HLHS) patients is important. A substantial number of families had relatives with undiagnosed CVMs, suggesting routine screening is beneficial.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatric Cardiology

Background:

  • Obstructive left-sided congenital heart lesions, such as bicuspid aortic valve, show familial clustering, leading to standard echocardiographic screening in relatives.
  • Hypoplastic left heart syndrome (HLHS) is a severe left-sided obstructive lesion, yet familial screening is not routinely recommended.

Purpose of the Study:

  • To determine the incidence of cardiovascular malformations (CVMs) in first-degree relatives of individuals with hypoplastic left heart syndrome (HLHS).

Main Methods:

  • Transthoracic echocardiography was used to screen 152 first-degree relatives (97 parents, 55 siblings) from 52 HLHS proband families.
  • Cardiovascular malformations were identified and categorized.

Main Results:

  • Overall, 17 of 152 relatives (11%) were diagnosed with CVMs, with 65% being previously undiagnosed.
  • Specific CVMs included bicuspid aortic valve (3%), dilated ascending aorta (3%), and coarctation of the aorta (1%).
  • Cardiovascular malformations were found in at least one relative in 27% of HLHS families.

Conclusions:

  • A significant incidence of CVMs exists in first-degree relatives of HLHS probands, underscoring the need for routine familial screening.
  • The high rate of previously undiagnosed CVMs, including dilated aorta, suggests that repeat screening in adulthood may be warranted.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
718
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
3.6K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
932
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
870
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
815